Chinese private hospitals face huge problems

We talk to a seasoned healthcare consultant just back from China on the three reasons why investing in Chinese hospitals may not be the blue-eyed bargain you might expect.

Report: The investor landscape in the Emerging Markets

Here we name and categorise the major investors in private healthcare services in the Developing World and get their view on the opportunities and problems they face. Developing World healthcare services have suddenly become wildly popular. New listed investment vehicles, such as GCC-based Amanat and Asian Healthcare Group in Malaysia have raised hundreds of millions of dollars with the promise of investing in healthcare services. Meanwhile, established private equity houses are launching funds worth up to $1bn and large healthcare services operators from Indonesia to Egypt are carrying out heavily oversubscribed IPOs on very high multiples.

Malo Clinic to open new low cost range of international dental clinics

Malo Clinic, the Portuguese outpatient healthcare group, is set to open a new brand of low cost dental clinics across the 28 countries it is already in. Malo began its internationalisation five years ago and has facilities from Angola to China and Colobia to Poland covering dentistry and cosmetic surgery, as well as an IVF clinic.

Operational challenges hinder China’s hospital privatisation

As the Chinese government aims to privatise healthcare, different models of integration are emerging. PPPs, private investments, and Sino-Foreign Joint Ventures (JVs) are the most common, although important operational challenges remain. We look at the issues.

Report: Global for-profit care home operators race into China

Healthcare Nova looks at the potential for residential care in China, names all the major foreign players active in the sector and talks to operators running homes today in China. How best can companies enter the market? And how large is it? What are the price points charged today for high-end care? By Helen Burgraff

Patient records recruit B2C

The former Innovation Director at Belgium’s National Union of Health Insurance Funds, chronic disease management guru Jan van Emelen is trying to make patient records work better. Like Dr. Mohammad Al-Ubaydli of the UK’s Patients Know Best, van Emelen is creating records that are owned and controlled by patients, rather than clinicians - but, unlike his peer in the UK, van Emelen is recruiting on a business-to-consumer (B2C) basis with funding from big pharma. With 17,000 patients already enrolled, will his different approach pay off?

Find Us